Odisha Pharma Summit 2025 positions State as eastern India’s emerging life sciences hub: CM Majhi
Odisha aims to become a leading pharmaceutical and medical device investment hub, as highlighted at the Odisha Pharma Summit 2025.

The summit was organised by the Government of Odisha in association with FICCI in Bhubaneswar. The event marked a milestone in Odisha’s industrial diversification journey, bringing together industry leaders, global manufacturers, Med Tech innovators, researchers, investors, and policymakers on a single platform. Odisha Pharma Summit 2025 showcased the State’s growing strengths in Pharmaceuticals, Medical devices manufacturing, progressive policy framework, infrastructure readiness, and skilled manpower, positioning Odisha as an emerging destination in India’s Pharmaceuticals & Medical Devices value chain.
The summit witnessed strong investor response, with a total of 45 Memoranda of Understanding (MoUs) signed across pharmaceuticals, medical technologies, and industrial infrastructure. These MoUs represent an investment commitment of Rs 6,263 crore, with an estimated employment generation potential of 38,406 jobs, reinforcing Odisha’s focus on inclusive, employment-intensive, and sustainable industrial growth.
The summit witnessed the participation of over 300 organisations and more than 400 delegates, representing the entire life sciences value chain including APIs, bulk drugs, formulations, vaccines, diagnostics, medical devices, healthcare services, research institutions, skilling partners, industry associations and Students.
The key highlight of the summit was the launch of the Odisha Pharmaceutical and Medical Devices Policy 2025, a forward-looking policy aimed at building a globally competitive, innovation-led, and employment-oriented life sciences ecosystem in the State. The policy offers a comprehensive framework covering infrastructure development, investment facilitation, research and development, skill development, and targeted incentives for pharmaceuticals and medical devices manufacturing.
The Chief Minister also unveiled two new industrial parks one dedicated to pharmaceuticals Park at Khordha-Nayagarh and the second to Medical Devices Manufacturing Park at Khordha. These parks are equipped with industrial infrastructure, common utilities, testing and certification facilities, and compliance-ready ecosystems to enable faster project implementation and ease of operations.
“Odisha is ready to emerge as a leading hub for pharmaceuticals and medical devices in India. With our new Odisha Pharmaceutical and Medical Devices Policy 2025 and pharma parks, we offer one of the country’s most competitive ecosystems for investment, innovation and jobs. I invite industry leaders to come, invest in Odisha and join us in this transformative journey yahi samay hai, sahi samay hai," said Majhi. He emphasised that Odisha’s strategic coastal location, port-led connectivity, and transparent governance framework make it uniquely positioned to attract global pharmaceutical and Medical Devices Manufacturing investments.
Minister for Industries, Skill Development & Technical Education, Sampad Chandra Swain, said, “The Odisha Pharma Summit 2025 reflects our State’s sector-focused industrialisation strategy. With progressive policies, dedicated industrial parks, skilled manpower, and proactive governance, Odisha offers a compelling value proposition for pharmaceutical and medical device manufacturers.”
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.